personalisation

R&D

A complex biological landscape of protein function unlocked ...

Promise Bio’s advanced AI-driven system integrates proteomics and multi-omics data, focusing on PTMs to identify unique biomarkers % disease pathways.

Sales & Marketing

Harnessing AI to transform end-to-end customer engagement fo...

AI can now deliver hyper-personalised, adaptive HCP journeys at scale.

Sales & Marketing

pharmaphorum podcast Episode 243, Lisa Sims, Novartis

On quality data for quality learnings, with Lisa Sims

Nicole Raleigh speaks with Lisa Sims, executive director of learning strategy & operations at Novartis, about personalising learning at scale.

Patients

Patient in hospital bed, engaged with care information

Moving beyond the pill: Unlocking value through engaged, emp...

Creating an environment where the patient is recognised as an active participant in their care journey is critical.

Oncology

ESMO 2025 in review: A new era in oncology, from AI to next-...

ESMO 2025 reflected a field in the midst of rapid evolution – one that is increasingly defined by personalisation and data-driven decision-making.

Patients

Purposeful prescribing in bipolar I disorder care

Purposeful prescribing is the idea of making thoughtful, patient-centred decisions about medication.